Cornerstone Planning Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Cornerstone Planning Group's ABBV Position: Q2 2026 in Review
Cornerstone Planning Group increased its AbbVie (ABBV) stake by 2.1% in Q2 2026, buying an estimated $7.32K and bringing the position to 1,687 shares worth $427K. The position accounts for 0.05% of the portfolio, ranked #114.
Cornerstone Planning Group first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $576K in Q4 2023. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cornerstone Planning Group held 1,687 shares of AbbVie worth $427K as of Q2 2026.
- Cornerstone Planning Group bought 34 AbbVie shares in Q2 2026, an estimated $7.32K.
- AbbVie made up 0.05% of Cornerstone Planning Group's portfolio in Q2 2026, its #114 holding.
- Cornerstone Planning Group first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
- Cornerstone Planning Group's AbbVie position peaked at $576K in Q4 2023.
- 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.